Nemorosone
Based on 1 Customer Validation
Nemorosone is the main component of the floral resin of Clusia rosea. Nemorosone has an antiproliferative effect on cancer cells. Nemorosone induces apoptosis in HT-29 and LoVo cells.
For research use only. We do not sell to patients.
- Purity : 99.0%
- CAS No.: 351416-47-2
- Formula: C33H42O4
- Molecular Weight:502.68
-
Storage:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
IC50 & Target
apoptosis[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
6.23 μg/mL
Compound: Nemorosone
|
Cytotoxicity against cisplatin-resistant human A2780 cells after 24 hrs
Cytotoxicity against cisplatin-resistant human A2780 cells after 24 hrs
|
[PMID: 18951805] |
| A2780 | IC50 |
6.75 μg/mL
Compound: Nemorosone
|
Cytotoxicity against doxorubicin-resistant human A2780 cells after 24 hrs
Cytotoxicity against doxorubicin-resistant human A2780 cells after 24 hrs
|
[PMID: 18951805] |
| A2780 | IC50 |
9.2 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human A2780 cells after 24 hrs
Cytotoxicity against human A2780 cells after 24 hrs
|
[PMID: 18951805] |
| HCT-8 | IC50 |
4.07 μg/mL
Compound: Nemorosone
|
Cytotoxicity against SN38-resistant human HCT8 cells after 24 hrs
Cytotoxicity against SN38-resistant human HCT8 cells after 24 hrs
|
[PMID: 18951805] |
| HCT-8 | IC50 |
4.23 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human HCT8 cells after 24 hrs
Cytotoxicity against human HCT8 cells after 24 hrs
|
[PMID: 18951805] |
| HCT-8 | IC50 |
4.44 μg/mL
Compound: Nemorosone
|
Cytotoxicity against raltitrexed-resistant human HCT8 cells after 24 hrs
Cytotoxicity against raltitrexed-resistant human HCT8 cells after 24 hrs
|
[PMID: 18951805] |
| HEK293 | IC50 |
4.2 μg/mL
Compound: Nemorosone
|
Cytotoxicity against HEK293 cells after 24 hrs
Cytotoxicity against HEK293 cells after 24 hrs
|
[PMID: 18951805] |
| HeLa | IC50 |
2.9 μM
Compound: 3, Natural NEM
|
Cytotoxicity against human HeLa cells after 72 hrs by resazurin assay
Cytotoxicity against human HeLa cells after 72 hrs by resazurin assay
|
[PMID: 22944119] |
| HeLa | IC50 |
3.3 μM
Compound: nemorosone
|
Cytotoxicity against human HeLa cells after 24 to 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 to 48 hrs by MTT assay
|
[PMID: 19497755] |
| HT-29 | IC50 |
3.5 μg/mL
Compound: Nemorosone
|
Cytotoxicity against SN38-resistant human HT-29 cells after 24 hrs
Cytotoxicity against SN38-resistant human HT-29 cells after 24 hrs
|
[PMID: 18951805] |
| HT-29 | IC50 |
5.18 μg/mL
Compound: Nemorosone
|
Cytotoxicity against 5-FU-resistant human HT-29 cells after 24 hrs
Cytotoxicity against 5-FU-resistant human HT-29 cells after 24 hrs
|
[PMID: 18951805] |
| HT-29 | IC50 |
5.25 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human HT-29 cells after 24 hrs
Cytotoxicity against human HT-29 cells after 24 hrs
|
[PMID: 18951805] |
| Jurkat | IC50 |
4.6 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human Jurkat cells after 24 hrs
Cytotoxicity against human Jurkat cells after 24 hrs
|
[PMID: 18951805] |
| K562 | IC50 |
4.2 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human K562 cells after 24 hrs
Cytotoxicity against human K562 cells after 24 hrs
|
[PMID: 18951805] |
| LNCaP | IC50 |
1.81 μg/mL
Compound: Nemorosone
|
Cytotoxicity against etoposide-resistant human LNCAP cells after 24 hrs
Cytotoxicity against etoposide-resistant human LNCAP cells after 24 hrs
|
[PMID: 18951805] |
| LNCaP | IC50 |
2.12 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human LNCAP cells after 24 hrs
Cytotoxicity against human LNCAP cells after 24 hrs
|
[PMID: 18951805] |
| MCF7 | IC50 |
3.3 μg/mL
Compound: Nemorosone
|
Cytotoxicity against 5-FU-resistant human MCF7 cells after 24 hrs
Cytotoxicity against 5-FU-resistant human MCF7 cells after 24 hrs
|
[PMID: 18951805] |
| MCF7 | IC50 |
4.28 μg/mL
Compound: Nemorosone
|
Cytotoxicity against doxorubicin-resistant human MCF7 cells after 24 hrs
Cytotoxicity against doxorubicin-resistant human MCF7 cells after 24 hrs
|
[PMID: 18951805] |
| MCF7 | IC50 |
4.37 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human MCF7 cells after 24 hrs
Cytotoxicity against human MCF7 cells after 24 hrs
|
[PMID: 18951805] |
| MCF7 | IC50 |
5.2 μM
Compound: 3, Natural NEM
|
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin assay
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin assay
|
[PMID: 22944119] |
| MIA PaCa-2 | IC50 |
2.4 μM
Compound: 3, Natural NEM
|
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by resazurin assay
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by resazurin assay
|
[PMID: 22944119] |
| NCI-H460 | IC50 |
4.21 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human H460 cells after 24 hrs
Cytotoxicity against human H460 cells after 24 hrs
|
[PMID: 18951805] |
| NIH3T3 | IC50 |
>50 μg/mL
Compound: Nemorosone
|
Cytotoxicity against Swiss mouse 3T3 cells after 24 hrs
Cytotoxicity against Swiss mouse 3T3 cells after 24 hrs
|
[PMID: 18951805] |
| PC-3 | IC50 |
2.01 μg/mL
Compound: Nemorosone
|
Cytotoxicity against human PC3 cells after 24 hrs
Cytotoxicity against human PC3 cells after 24 hrs
|
[PMID: 18951805] |
In Vitro
Nemorosone (0-50 μM; 24-72 h) inhibits the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively[1].
Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) increases the percentage of G0/G1 phase cells[1].
Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) induces apoptosis in both cell lines[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT-29 and LoVo cells
-
Concentration:0-50 μM
-
Incubation Time:24-72 h
-
Result:Inhibited the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively.
-
Cell Line:HT-29 and LoVo cells
-
Concentration:25.7 μM for HT-29; 22.8 μM for LoVo
-
Incubation Time:24, 48 hours
-
Result:Increased the percentage of G0/G1 phase cells.
-
Cell Line:HT-29 and LoVo cells
-
Concentration:25.7 μM for HT-29; 22.8 μM for LoVo
-
Incubation Time:24, 48 hours
-
Result:Induced apoptosis in both cell lines.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Athymic NMRI nu/nu nude mices (6 to 8 week old female), which had 100 mm3 MIA-PaCa-2 xenograft tumor[2]
-
Dosage:50 mg/kg
-
Administration:Daily i.p. injections for 28 days
-
Result:Showed a significant growth-inhibitory effect in pancreatic cancer xenografts[2].
Chemical Information
-
CAS No. 351416-47-2
-
Appearance Solid
-
Molecular Weight 502.68
-
Formula C33H42O4
-
Color White to off-white
-
SMILES
O=C(C1=CC=CC=C1)[C@@]23C([C@@](C(C(C/C=C(C)/C)=C2O)=O)(C[C@H](C/C=C(C)/C)C3(C)C)C/C=C(C)/C)=O
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Frión-Herrera Y, Gabbia D, Scaffidi M, et al. The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells. Int J Mol Sci. 2020;21(5):1827. Published 2020 Mar 6. [Content Brief]
[2]. Wolf RJ, et al. In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One. 2013;8(9):e74555. Published 2013 Sep 5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)